None
Quote | Myomo Inc. (NYSE:MYO)
Last: | $3.64 |
---|---|
Change Percent: | -0.82% |
Open: | $3.71 |
Close: | $3.64 |
High: | $3.766 |
Low: | $3.57 |
Volume: | 149,403 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | Myomo Inc. (NYSE:MYO)
2024-05-08 22:03:09 ET Myomo, Inc. (MYO) Q1 2024 Earnings Conference Call May 08, 2024 04:30 PM ET Company Participants Kim Golodetz - LHA Investor Relations Paul Gudonis - Chief Executive Officer Dave Henry - Chief Financial Officer Conference Call Partici...
2024-05-08 16:33:11 ET More on Myomo Myomo's Revolutionary MyoPro Brace: A Buy In Neurological Mobility Aid Myomo, Inc.: In Motion To Accelerating Revenue Growth Myomo, Inc. (MYO) Q4 2023 Earnings Call Transcript Myomo gets first lump sum reimbursements for M...
Message Board Posts | Myomo Inc. (NYSE:MYO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $MYO News Article - Myomo Reports Fourth Quarter and Full Year 2022 Financial Results | whytestocks | investorshangout | 03/13/2023 12:45:45 PM |
$MYO https://investorshub.advfn.com/uimage/uploads/2023/3/12/osjzworiginal_ | riskyron | investorshub | 03/12/2023 3:20:34 PM |
MYO...GAPPING ON A BIG FAT RED DAY | TrendTrade2016 | investorshub | 03/10/2023 1:27:37 PM |
MYO. Ready to go! | TrendTrade2016 | investorshub | 03/10/2023 9:42:46 AM |
whytestocks: $MYO News Article - 10 Hot Penny Stocks Under $1 To Watch This Week | whytestocks | investorshangout | 03/09/2023 7:40:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Record 275 patients in backlog, includes 180 authorizations and orders in Q1, up 48% over the prior year Record 493 MyoPro candidates added to the pipeline in Q1 Revenue of $3.8 million, up 9% over the prior year Conference call begins at 4:30 p.m. Eastern time today ...
Claims Remitted for Payment by All Four Billing Regions Orthotics and Prosthetics Providers Beginning to Receive Reimbursement at Published Rates Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for th...